A plausible structure of the iron-molybdenum cofactor of nitrogenase [reduced ferredoxin:dinitrogen oxidoreductase (ATP-hydrolyzing), EC 1.18.6.1] is presented based on altered substrate reduction properties of dinitrogenase containing homocitrate analogs within the cofactor. Alterations on each carbon of the four-carbon homocitrate backbone were correlated with altered substrate reduction properties of dinitrogenase containing these analogs. Altered substrate reduction properties are the basis for a model in which homocitrate is oriented about two cubane metal clusters.
Biological systems utilize nitrogenase (EC 1.18.6.1) to catalyze the ATP-and reductant-dependent reduction of N2 to ammonium. Nitrogenase consists of two proteins: dinitrogenase (MoFe protein, or component I) and dinitrogenase reductase (Fe protein, or component II) (1, 2) . Each electron transferred to dinitrogenase by dinitrogenase reductase is coupled to the hydrolysis of two MgATP molecules (3) .
Electrons passed to dinitrogenase are channeled to a unique prosthetic group called the iron-molybdenum cofactor (FeMo-co) (4, 5) , which is the ultimate site of substrate reduction.
FeMo-co has been the subject of numerous elemental analyses and the latest data indicate a Mo/Fe/S/homocitrate ratio of 1:7 ± 1:8 ± 1:1 (6, 7). FeMo-co has been subjected to spectroscopic analyses, both in dinitrogenase and in isolated forms (8) (9) (10) (11) (12) (13) (14) (15) (16) . Extended x-ray absorption fine structure (EXAFS) data indicate that FeMo-co has two or three iron atoms linked to molybdenum via bridging sulfur atoms and that the remaining iron atoms are more distant (10) (11) (12) (13) (14) .
EXAFS data also suggest two or three light (0, N) ligands to molybdenum. How FeMo-co is coordinated to apodinitrogenase is not known (17) .
Since the isolation of FeMo-co, significant contributions have been made toward the synthesis of Fe-Mo-S complexes as possible analogs of the active site of nitrogenase. Although the "linear" and "cubane" type of clusters reported earlier (18, 19) do not possess Fe/Mo/S ratios consistent with the range of ratios reported for FeMo-co, cubane clusters have Mo-S distances comparable to those observed by EXAFS in FeMo-co. Cubane clusters also contain Mo atoms in an oxidation state of 3+ to 4+, which is in agreement with external nuclear double resonance (ENDOR) studies (16) . On the other hand, linear clusters contain Mo in a relatively high oxidation state (Mo5+, Mo6+) and shorter Mo-S distances.
Recently, S-bridged Mo-bicubane structures with catechol ligands have been synthesized as possible analogs of FeMo-co (20) (21) (22) , and the authors suggested the feasibility of assembling MoFe3S4 and Fe4S4 units into S-bridged doublecubane clusters. The mixed-cubane clusters possess an Fe/ Mo/S stoichiometry similar to that of FeMo-co, with at least four distinct iron sites compatible with ENDOR results of FeMo-co (15) . Doubly Mo-capped prismane clusters have been synthesized (23) , but these clusters contain Fe/Mo ratios of 6:2. Mono-capped species were not isolated, even though these species are suggested to be in equilibrium with the di-capped cluster in solution.
In spite of extensive efforts by many groups, no functional analog of FeMo-co capable of occupying the active site of nitrogenase has been synthesized. FeMo-co contains 1 mol of homocitrate per Mo (7), however, no FeMo-co analog synthesized or suggested to date includes homocitrate.
An in vitro system for the synthesis of FeMo-co has been developed that requires molybdate, MgATP, dithionite, at least the nijR, nifN, and niJE gene products (24) , dinitrogenase reductase (25) (26) (27) , and homocitrate (7, 28) . The in vitro FeMo-co synthesis system allows the incorporation of homocitrate and its analogs (i.e., citrate, isocitrate, and homoisocitrate) to produce modified forms of FeMo-co (29) (30) (31) . The resulting aberrant forms of FeMo-co exhibit altered substrate specificities and inhibitor susceptibilities and the six-electron reduction of N2 by nitrogenase was dramatically affected by substitution of any other organic acid for homocitrate in the in vitro FeMo-co synthesis system. These data suggest that none of the FeMo-co analogs tested would produce a dinitrogenase capable of supporting significant diazotrophic growth.
Imperial et al. (30) described the structural requirements of an organic acid moiety of FeMo-co competent for substrate reduction: (i) stereochemistry at the chiral C-2 carbon analogous to that of the R isomer of homocitrate; (ii) a hydroxyl group on the chiral carbon atom; (iii) a carboxyl group on the chiral carbon atom; (iv) a carboxyl group a to the chiral center; and (v) a four-to six-carbon chain containing two terminal carboxyl groups.
To test this model further, the two diastereomers of fluorohomocitrate were utilized with a range of substrates (e.g., cyanide) and inhibitors (e.g., carbonyl sulfide) of nitrogenase (31) . Dinitrogenase activated with FeMo-co synthesized using threo-fluorohomocitrate reduces protons, cyanide, and acetylene but cannot reduce N2. In addition, proton reduction is inhibited by carbon monoxide (CO), a characteristic of dinitrogenase from NifV-mutants. Dinitrogenase activated with FeMo-co synthesized using erythrofluorohomocitrate reduces protons, cyanide, acetylene, and N2. In this case, proton reduction is not inhibited by CO, a characteristic of the wild-type enzyme.
In this paper we further investigate the properties of dinitrogenase containing homocitrate analogs in which the chirality of the C-2 carbon has been altered [(R)-citroylformate, and (S)-citroylformate] or the C-2 hydroxyl group has been altered (3- (33) . (R)-Citroylformate, (S)-citroylformate, and 3-hydroxyglutamate were gifts of Kiyofumi Maruyama (Gifu University, Gifu, Japan). threoFluorohomocitrate and erythro-fluorohomocitrate were synthesized as described (31) .
FeMo-co Models. All available chemical and biochemical evidence was converted into internal coordinates (bond lengths, bond angles, dihedral angles, and distances between atoms) (11, 34) . Models compatible with these coordinates were created and minimized with metric matrix distance geometry algorithms of the DSPACE program (Hare Research, Woodinville, WA). Additional manual manipulations were performed with the molecular modeling program INSIGHTII (Biosym Technologies, San Diego).
RESULTS AND DISCUSSION
In preliminary experiments, various concentrations of homocitrate analogs were tested for their ability to yield reconstituted dinitrogenase competent for acetylene reduction. The lowest concentration of organic acid that generated maximum acetylene reduction was chosen for the assays presented in Table 1 . Substrate reduction properties of dinitrogenase activated with some homocitrate analogs have been reported (30, 31) . The experiments have been repeated for this report so that all results could be compared. Dinitrogenase capable of proton reduction can be formed in vitro with many analogs ofhomocitrate incorporated into FeMo-co (29) (30) (31) . However, the ability to reduce acetylene was more sensitive to modifications of the homocitrate structure, and only homocitrate, erythro-fluorohomocitrate, or R-citroylformate was able to produce a dinitrogenase capable of significant N2 reduction (Table 1) .
What follows is a discussion concerning alterations on each carbon of the four-carbon homocitrate backbone and the corresponding effects on the properties of dinitrogenase containing homocitrate analogs with these alterations. A model of FeMo-co based on properties of dinitrogenases containing homocitrate analogs is presented in Fig. 1 . This model does not include contributions from the protein higands, which are of obvious importance. In this model, (30, 31) , along with 0.2 ml of an ATP-regenerating mixture that contained 5 mM sodium dithionite and 0.05 mM sodium molybdate and the indicated concentrations of organic acids. Reaction mixtures were incubated at 300C for 35 min, after which 0.8 ml of additional ATP-regenerating mixture containing 5 mM sodium dithionite was added, together with purified dinitrogenase reductase (24) , and the activity was assayed. ND, not determined. Addition of excess purified FeMo-co to UW45 extracts used in these experiments resulted in an activity of 44.9 nmol of ethylene formed per minute per assay. *Homocitrate lactone (Sigma) was converted to the free acid by adjusting the solution to pH 10 (20, 22) .
The C- Table 1 shows that dinitrogenase containing R-citroylformate and S-citroylformate will reduce N2 45% and 3.5% as effectively as homocitratecontaining dinitrogenase, respectively. In addition, dinitrogenase containing R-citroylformate or S-citroylformate will reduce acetylene 63% and 10% as well as homocitratecontaining dinitrogenase, respectively. Proton reduction activity of dinitrogenase containing S-citroylformate is inhibited by CO, whereas no CO inhibition of proton reduction is observed for dinitrogenase containing R-citroylformate.
Dinitrogenase activated with the racemic mixture of citroylformate reduces N2, acetylene, and protons similarly to the R-citroylformate-containing dinitrogenase, and proton reduction activity is not inhibited by CO. If the FeMo-co synthesis system is unable to discriminate between the two isomers, then CO inhibition of proton reduction by dinitrogenase activated by FeMo-co synthesized with the racemic mixture should be -27%. Since similar properties are observed when dinitrogenase is activated with FeMo-co synthesized with either R-citroylformate or the racemic mixture, it seems that R-citroylformate is preferentially incorporated into dinitrogenase. The R isomer of homocitrate seems to be required for the synthesis of active FeMo-co. Only the R isomer of homocitrate is synthesized in biological systems (28). Imperial et al. (30) have shown that the substrate reduction properties of dinitrogenase containing R-citramalate or D-malate are markedly different from those of dinitrogenases containing the corresponding S-citramalate or L-malate isomers. Dinitrogenase containing R-citramalate or S-citramalate reduces acetylene 40%o and 7% as effectively as homocitrate-containing dinitrogenase, respectively (Table 1) . Fig. 1 shows FeMo-co containing R-homocitrate, which positions the C-2 hydroxyl group away from the metal-bound N2 molecule. However, analogous coordination using S-homocitrate would place the hydroxyl group close to the substrate binding site. Such close proximity of the hydroxyl group could explain the dramatic differences between dinitrogenases activated with R and S analogs of homocitrate.
The C- (Table 1 ). Both dinitrogenases have high proton reduction activities that do not suffer from CO inhibition. In addition, dinitrogenases containing R-citroylformate will reduce N2 and acetylene 45% and 63% as effectively as homocitrate-containing dinitrogenase, respectively.
Dinitrogenase containing erythro-fluorohomocitrate exhibits substrate reduction properties similar to those of R-citroylformate-containing dinitrogenase. The arrangement of homocitrate around the metal clusters of FeMo-co shown in Fig. 1 places the erythro fluorine atom of erythrofluorohomocitrate and the carbonyl oxygen atom of R-citroylformate in the same region, when these analogs are substituted for homocitrate. The staggered conformation of the tail region of homocitrate allows the substituents of C-4 to be in similar proximity to that of the erythro atom on C-1.
Citrate lacks the C-4 carbon of homocitrate. Therefore, when citrate is arranged around the two cubanes the FeMo-co molecule becomes distorted. Citrate may rearrange around the clusters to place the C-1 carbonyl oxygen atom (and the electron pairs) in close proximity to the substrate binding site. Similarly, this model predicts that FeMo-co containing threo-fluorohomocitrate places the fluorine atom (and its electron pairs) in close proximity to the proposed substrate binding site. In addition, proton reduction by dinitrogenase containing either citrate or threo-fluorohomocitrate is inhibited 59% by CO.
Role for the Hydroxyl Group of Homocitrate or Its Analogs. The hydroxyl group is required for FeMo-co synthesis (29, 30) . Both homocitrate and citrate contain a C-2 hydroxyl group, whereas homoisocitrate and isocitrate contain the hydroxyl group on the C-1 carbon. Dramatic differences in substrate reduction properties are observed between dinitrogenases containing homocitrate or homoisocitrate (as well as citrate or isocitrate). This may be due to an altered orientation of FeMo-co when attached to apodinitrogenase, since the hydroxyl group may be required to anchor the cofactor to the protein.
Dinitrogenase containing 3-hydroxyglutamate has significant acetylene and proton reduction activities, with proton reduction not inhibited by CO. However, dinitrogenase containing 3-carboxyglutamate (in this case the hydroxyl group is replaced with a carboxyl group) exhibits poor substrate reduction activity (Table 1) . Therefore, the C-2 hydroxyl group of homocitrate analogs cannot be replaced with a carboxyl group to form a functional FeMo-co. In this model, the best fit to the DSPACE molecular modeling parameters is obtained when the hydroxyl group is positioned out of the ligation sphere of molybdenum or iron. This suggests another role, such as binding to the protein, for the hydroxyl group.
Models Containing a Five-Membered Ring Ligating Molybdenum. The seven-membered ring model of FeMo-co (Fig. 1) shows the C-1 and C-2 carboxyl groups of homocitrate coordinated to the molybdenum atom of one cluster while the C-4 carboxyl group is coordinated to one Fe of the other cluster. Seven-membered ring structures of tricarboxylates (e.g., citrate and isocitrate) coordinated to an octahedral (Fe) atom have been reported (34) . However, a five-membered ring can be constructed that coordinates the C-2 hydroxyl and carboxyl groups of homocitrate to the molybdenum center (not shown). This five-membered ring structure coordinates the C-1 carboxyl group to the 4Fe-4S cluster and can position the threo hydrogen close to the substrate binding site, or it can arrange to interfere with the carbonyl oxygen of the five-membered ring. Evidence favoring the five-membered ring over the seven-membered ring includes the following: (i) five-membered rings are entropically more favorable than seven-membered rings; (ii) other organic acid/metal cluster models exist showing five-membered rings containing carboxyl-metal-hydroxyl coordination (36) ; and (iii) isolated FeMo-co contains a net negative charge, which may be due to a free carboxyl group. However, this five-membered ring model is unable to explain how alterations in the tail (i.e., C-3 and C-4) region of homocitrate affect the substrate reduction properties of dinitrogenase containing the corresponding homocitrate analogs. In addition, this model cannot explain the effects of C-1 hydroxyl acids when incorporated into FeMo-co. Therefore, Fig. 1 seems the best representation of FeMo-co based on substrate reduction properties of FeMo-co containing homocitrate analogs.
A model with a five-membered ring structure, but coordinating the C-4 carboxyl group to the 4Fe-4S cluster, was also constructed (not shown). Although this model does not explain differences in substrate reduction data for substituents placed on the C-1 carbon (erythro-vs. threofluorohomocitrate), it may explain how alterations in the tail region of homocitrate affect substrate reduction properties. Energy differences between this model and the fivemembered ring model discussed above are quite small, and this indicates that substitution of citrate for homocitrate in this model would have minor effects. Therefore, the dramatic differences in N2 reduction observed between homocitratecontaining dinitrogenase and citrate-containing dinitrogenase do not make this model plausible. The dramatic differences in substrate reduction properties of dinitrogenase containing R vs. S analogs of homocitrate also may rule out the possibility ofa five-membered homocitrate-metal ring in FeMo-co.
A Pentlandite Model of FeMo-co. Pentlandite models of FeMo-co (22, 37) possess a reasonable Fe/Mo/S stoichiometry and are in fair agreement with much of the spectroscopic data acquired on FeMo-co. An attractive feature of the model (not shown) is a five-membered Mo ring that includes the C-2 carboxyl and hydroxyl groups of homocitrate. However, negative features of the pentlandite model include (i) a nine-membered ring containing iron and homocitrate, (ii) no binuclear (Mo-substrate-Fe) interaction as previously proposed (35) , and (iii) no easy explanation for the dramatic differences between dinitrogenase containing homocitrate analogs possessing a C-1 fluorine (or hydroxyl group) at the erythro vs. threo position. According to this model, FeMo-co containing citrate would have an eight-membered citrate-Fe ring, whereas homocitrate would have a nine-membered ring. Even though the eight-membered citrate-Fe ring is entropically favorable, substrate reduction activities of dinitrogenase containing this analog are substantially lower than the dinitrogenase containing homocitrate. However, it is possible that shortening the tail region of homocitrate by one carbon may move the C-1 carboxyl group away from the substrate binding site in dinitrogenase containing citrate.
The pentlandite model does not explain differences in substrate reduction properties of dinitrogenase containing (R)-vs. (S)-citroylformate. In a five-membered ring conformation (not shown), (S)-citroylformate would orient in an inverted manner when compared with FeMo-co containing (R)-citroylformate or (R)-homocitrate. Since both isomers contain four-carbon backbones with two terminal carboxyl groups, both normal and inverted orientations can effectively coordinate one carboxyl group to an Fe atom, with the remaining carboxyl group available for effective proton donation. Therefore, proton donation via the C-4 carboxyl of the S analog (instead of the C-1 carboxyl of the R analog) should be unaffected. In fact, the more flexible tail region should conform more easily to place the carboxyl group near the substrate binding site with the S isomer. In addition, the S isomer would give an eight-membered Fe ring, which is more desirable than the nine-membered ring associated with R isomers. However, poor substrate reduction is observed with (S)-citroylformate compared with (R)-citroylformate. Therefore, the dramatic differences in substrate reduction observed between dinitrogenase containing (R)-vs. (S)-citroylformate do not make this model highly plausible.
CONCLUSION
The bicubane model presented here is based on (i) metric matrix distance geometry algorithms of the DSPACE program (Hare Research), (ii) spectroscopic (e.g., EXAFS) data acquired on FeMo-co (11, 12) , and (iii) the substrate reduction properties of dinitrogenases containing homocitrate analogs. Although other possible models presented did not fit the constraints imposed by the altered substrate reduction properties of dinitrogenases containing homocitrate analogs, the data presented here should stimulate future modeling and synthesis of the active site of nitrogenase. The fact that so many organic acids can be incorporated to make FeMo-co analogs should provide bioinorganic chemists with many avenues of cofactor synthesis and insight into the mechanism of N2 reduction.
